| Financial Year |
March 31 2023 |
| Monetary Funds |
4,229,349,230.52 |
| Held-for-trading Financial Assets |
144,557,083.73 |
| Notes Receivable |
810,790,007.67 |
| Accounts Receivable |
7,074,568,785.40 |
| Advances to Suppliers |
2,562,528,843.57 |
| Other Receivables |
431,654,194.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,746,885,661.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
573,929,788.20 |
| Other Current Assets |
592,317,064.26 |
| Total Current Assets |
25,506,753,231.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,798,418.06 |
| Long-term Equity Investment |
50,388,586.66 |
| Investment Properties |
271,107,683.07 |
| Fixed Assetes |
2,378,178,339.35 |
| Under-construction Projects |
67,104,280.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
633,016,514.45 |
| R&D expenses |
152,374.65 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
117,511,643.05 |
| Deferred Income Tax Assets |
526,564,613.01 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,677,233,033.37 |
| Total Assets |
31,183,986,264.96 |
| Short-Term Loans |
3,152,756,733.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,045,807,894.11 |
| Accounts Payable |
5,342,315,270.56 |
| Accounts Received In Advance |
20,148,282.00 |
| Employee Compensation Payable |
218,479,517.25 |
| Taxes Payable |
278,237,726.31 |
| Interest Payable |
-- |
| Dividend Payable |
246,000,000.00 |
| Other payables |
1,117,429,422.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,525,212.46 |
| Other Current Liabilities |
205,369,292.41 |
| Sub-Total of Current Liabilities |
18,778,208,164.99 |
| Long-term Loans |
33,670,115.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,070,408.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
28,457,591.40 |
| Deferred Income Tax Liabilities |
346,765,627.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,109,761,804.39 |
| Total Liabilities |
19,887,969,969.38 |
| Paid-In Capital(Or Share Stock) |
1,495,788,692.00 |
| Capital Surplus |
3,320,608,632.50 |
| Surplus Reserve |
211,356,217.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,060,612,642.30 |
| Minority Stockholder's Interest |
-47,486,880.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,343,503,175.77 |
| Owner's Equity（Stockholder's Equity） |
11,296,016,295.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,183,986,264.96 |
